Product Information
ATROPINE 1% EYE DROPS is a generic product labeled by Alcon Laboratories, Inc., priced at $19.9863 per ML under NDC 00065081702. Its NADAC has been published 116 times since Jul 17, 2024.
FDA first approved this application on Dec 1, 2016. Its Orange Book therapeutic-equivalence code is AT2.
The High Outlier badge above means this manufacturer's average price in the atropine sulfate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/mL
Manufacturer
Alcon Laboratories, Inc.NDC
00065081702
Classification
Generic
Dosage Form
SOLUTION
Route
OPHTHALMIC
Effective Date
9/23/2026
Active Ingredients
ATROPINE SULFATEApproval Type
New Drug (NDA)
FDA Application
NDA208151FDA Approved
12/1/2016
TE Code
AT2
On Market Since
11/1/2022
Pharmacological Classes
Price Statistics
The NADAC for ATROPINE 1% EYE DROPS has been published 116 times since Jul 17, 2024, and over the history we have for it it has risen 5.5%. The table below summarizes its recorded NADAC range and movement.
| Current price | $19.9863 per ML |
|---|---|
| All-time high | $20.0302 (May 13, 2026) |
| All-time low | $18.9529 (Jul 17, 2024) |
| 52-week high | $20.0302 |
| 52-week low | $19.6511 |
| Median price | $19.4558 |
| Average price | $19.4935 |
| Largest weekly change | +1.1% (Aug 20, 2025) |
| Weeks tracked | 116 |
| Tracking since | Jul 17, 2024 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 48% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Alcon Laboratories, Inc. manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
atropine sulfate market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Anticholinergic class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of ATROPINE 1% EYE DROPS?
The current National Average Drug Acquisition Cost (NADAC) for ATROPINE 1% EYE DROPS, manufactured by Alcon Laboratories, Inc., is $19.9863 per ML (NDC 00065081702), effective Sep 30, 2026.
How has the price of ATROPINE 1% EYE DROPS changed over time?
Over the history we have for it, the NADAC for ATROPINE 1% EYE DROPS has risen 5.5%. It has been tracked across 116 weekly CMS publications since Jul 17, 2024.
What are the highest and lowest recorded NADAC prices for ATROPINE 1% EYE DROPS?
Since Jul 17, 2024, the NADAC for ATROPINE 1% EYE DROPS has ranged from a low of $18.9529 (Jul 17, 2024) to a high of $20.0302 (May 13, 2026), with a median of $19.4558 per ML.
Are there cheaper alternatives to ATROPINE 1% EYE DROPS?
Yes. 1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, ATROPINE 1% EYE DROPS, is $10.3450 per ML — about 48% below ATROPINE 1% EYE DROPS.
Who manufactures ATROPINE 1% EYE DROPS?
ATROPINE 1% EYE DROPS (NDC 00065081702) is labeled by Alcon Laboratories, Inc., and CMS classifies it as a generic product.